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        B cell malignancies such as non-Hodgkin  ’  s 
lymphoma and multiple myeloma (MM) are 
characterized by 14q32 translocations involving 
the IgH locus (  1  ). These translocations serve to 
juxtapose IgH regulatory elements, such as the 
intronic enhancer (E    ;1) or 3     C     locus control 
region (LCR) (  2, 3  ), that deregulate transcrip-
tion of target genes over several hundred kilo-
bases of DNA. The mechanisms involved in 
long-distance deregulation of target genes by IgH 
regulatory elements are unknown; however, 
regulatory elements in the IgH locus are thought 
to derepress or increase the transcription of tar-
get genes such as   CMYC   (  1, 2  ) and   cyclin D1   
(  CCND1  ) (  1, 4  ) that are involved in B cell 
malignancies. Epigenetic changes in chromatin 
structure involving DNA methylation (  5  ) and/
or histone modifi  cations (  6  ) have been impli-
cated in deregulated gene expression (  4  ). 
  The activation of the   CCND1   gene that 
occurs in mantle cell lymphoma (MCL) and a 
subset of MM was used as a model system to 
investigate the mechanisms responsible for long-
distance gene deregulation in B cell malignancies 
(see   Fig. 1 A  ). Cyclin D1 is not expressed in 
normal lymphocytes, where the unlinked family 
members cyclin D2 and/or D3 are active (  7  ). In 
B cell malignancies, cyclin D1 gene expression 
is activated by the insertion or translocation of 
IgH regulatory elements, such as the E     intro  n  ic 
or 3     C     enhancer/LCR, that can be as far as 
100  –  300 kb away from the  CCND1   gene ( 4, 8 ). 
The majority of the breakpoints in MCL map 
to the major translocation cluster (MTC) re-
gion located     120 kb upstream (centromeric) 
of the   CCND1   gene (  8  ). The nearest gene to 
  CCND1  ,   MyeOV  , is located 360 kb centro-
meric to   CCND1   and is expressed in a subset 
of t(11;14) MM, but not in MCL (  9  ). Although 
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  In mantle cell lymphoma (MCL) and some cases of multiple myeloma (MM), cyclin D1 
expression is deregulated by chromosome translocations involving the immunoglobulin 
heavy chain (IgH) locus. To evaluate the mechanisms responsible, gene targeting was used 
to study long-distance gene regulation. Remarkably, these targeted cell lines lost the 
translocated chromosome (t(11;14)). In these MCL and MM cells, the nonrearranged   cyclin 
D1   (  CCND1  ) locus reverts from CpG hypomethylated to hypermethylated. Reintroduction of 
the translocated chromosome induced a loss of methylation at the unrearranged   CCND1   
locus, providing evidence of a transallelic regulatory effect. In these cell lines and primary 
MCL patient samples, the   CCND1   loci are packaged in chromatin-containing CCCTC binding 
factor (CTCF) and nucleophosmin (NPM) at the nucleolus. We show that CTCF and NPM are 
bound at the IgH 3     regulatory elements only in the t(11;14) MCL cell lines. Furthermore, 
NPM short hairpin RNA produces a specifi  c growth arrest in these cells. Our data demon-
strate transvection in human cancer and suggest a functional role for CTCF and NPM. 
© 2008 Liu et al.  This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the fi  rst six months after the publi-
cation date (see http://www.jem.org/misc/terms.shtml). After six months it is available 
under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 
Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).1844 TRANSVECTION IN MCL   | Liu et al. 
  The   CCND1   promoter contains a CpG island that can 
be potentially regulated by DNA methylation (  4, 11  ). We 
have found that in normal B cells the   CCND1   locus is 
translocations involving the t(11;14) are most common, the 
MM cell line U266 contains an insertion of IgH regulatory 
  sequences     10 kb centromeric of the   CCND1   promoter (  10  ). 
    Figure 1.         Derivative MCL and MM cell lines have lost t(11;14).   (A) Maps of the 11q13 and 14q32 regions with the locations of the gene target-
ing events. TV1 inserts the neo  R   gene into the MTC region,     120 kb upstream of the   CCND1   gene on chromosome 11. TV2 inserts a neo  R   gene  down-
stream of the human IgH 3      1 LCR region on chromosome 14. (B) Southern blot analysis of U266 parental (U) and TV1-transfected clones (U1  –  11). 
Maps of the vector, the endogenous locus, and the targeted clone U7 are shown. (C) Southern blot analysis of MCL parental and mutant cell lines. 
Genomic DNA from the Granta parental cell line (G) and its targeted derivatives (G4, LG1, and LG2) were analyzed with the Granta breakpoint (P519) 
probe, and genomic DNA from the parental cell line NCEB1 (N) and its targeted derivatives (N1, N2, and N3) were analyzed with the NCEB1 breakpoint 
(MTC) probe. Both parental lines have both translocated (Trans.) and nontranslocated (Nor.)   CCND1   loci, whereas the derivatives retain only the normal 
chromosome. The map depicts the locations of the cell line breakpoints. (D) FISH analysis of MCL parental and mutant cell lines. A centromeric probe 
for chromosome 11 and IgH/  CCND1   fusion probes revealed loss of the translocated t(11;14) in the derivative cells lines. A more detailed description is 
provided in Supplemental results (available at http://www.jem.org/cgi/content/full/jem.20072102/DC1). (E) FISH analyses show the presence of the vari-
ant t(11;14) insertion in the U266 MM cell line and its absence in derivative cell lines (LU1 and LU2). Table S1 provides a summary. Bars, 15   μ  m.     JEM VOL. 205, August 4, 2008 
ARTICLE
1845
malignancies. Our initial approach was to target the poten-
tial regulatory regions involved in long-distance cyclin D1 
deregulation in B cell malignancies. By analogy, results in 
the     -globin locus demonstrated that insertion of a selectable 
marker gene into the     -globin LCR abrogated transcription 
of downstream genes (  22  ). Two gene targeting vectors (TV1 
and 2;   Fig. 1 A  ) were constructed and electroporated into 
two MCL cell lines, Granta 519 (Granta [G]) and NCEB-1 
(NCEB [N]), and the MM cell line U266 (U), all of which 
express cyclin D1.   The initial Southern blot analysis was con-
sistent with successful gene targeting (  Fig. 1 B  ); however, 
subsequent analyses showed instability and loss of the targeted/
translocated chromosomes. Additional clones were isolated 
using TV1 in NCEB (N1  –  3) cells, and TV2 in U266 (LU 
clones) and Granta (LG clones) cells. Southern blot analysis 
using cell line  –  specifi  c translocation breakpoint probes (P519 
for Granta and MTC for NCEB) demonstrated the absence of 
translocated chromosome breakpoint sequences in the mutant 
MCL cell lines (  Fig. 1 C  ). Fluorescent in situ hybridization 
(FISH) analysis demonstrated that the translocated chromo-
somes had been lost in all of these clones (  Fig. 1, D and E  ; and 
Table S1, available at http://www.jem.org/cgi/content/full/
jem.20072102/DC1). 
  We assessed the expression of D-type cyclins in each of 
the parental and targeted MCL cells to determine whether 
loss of t(11;14) aff  ected expression of the remaining cyclin 
D alleles. Parental Granta and NCEB MCL cells expressed 
cyclin D1 (  4  ). However, the derivative MCL cell lines, 
which had lost t(11;14), did not express cyclin D1 (  Fig. 2, 
A and B  ). Instead, up-regulation of cyclin D3 mRNA (not 
  organized into hypomethylated DNA bound by acetylated 
nucleosomes. Analysis of the   CCND1   DNA methylation 
status in MM and MCL cell lines with t(11;14) indicates that 
the deregulated as well as the normal, silent   CCND1   loci 
are CpG hypomethylated (  4  ). 
  Control of DNA methylation in mammalian cells has been 
shown to involve a cis-acting mechanism (  12  ). However, ob-
servations in higher plants (  13  –  15  ), the fungus   Ascobolus immerses   
(  16  ), and more recently in mice (  13, 17  ) demonstrated that 
DNA methylation can also be regulated in trans by inter-
actions between homologous chromosomes. 
  A ubiquitous, complex protein that has emerged as a crit-
ical mediator of multiple epigenetic processes is the zinc 
fi  nger protein CCCTC binding factor (CTCF). CTCF is a 
highly conserved, 11 zinc fi  nger protein fi  rst identifi  ed as a 
c-myc binding factor and subsequently shown to bind to meta-
zoan regulatory elements known as insulators (  18  ). Insulator 
elements, which act from an intervening position to prevent 
fl  anking cis-acting elements from interacting, mediate their 
function through CTCF (  18, 19  ). Furthermore, the binding 
of CTCF to insulator elements is blocked by CpG methyla-
tion, allowing interactions between distal regulatory elements 
in the imprinted   Igf2/H19   locus (  19, 20  ). Recent evidence 
has identifi  ed the nucleolar protein nucleophosmin (NPM) as 
a major CTCF-interacting protein that functions to tether 
promoters and regulatory elements separated by large linear 
distances together at the nucleolar periphery (  21  ). 
  To investigate the mechanisms of long-distance activation 
of the   CCND1   gene by the IgH enhancer/LCR, homolo-
gous recombination was used to target regulatory regions po-
tentially involved in cyclin D1 deregulation. Recombinants 
that lost the translocated chromosome also lost the ability 
to maintain hypomethylation at the normal   CCND1   allele. 
These clones no longer expressed cyclin D1. These fi  ndings 
suggest that the translocated chromosome exerts a long-dis-
tance cis DNA hypomethylating eff  ect on the linked   CCND1   
promoter as well as a transallelic eff  ect on the unlinked   CCND1   
promoter on the homologous chromosome. Thus, in the 
absence of the translocated chromosome, the unrearranged 
  CCND1   locus is densely DNA methylated. CTCF and NPM 
are associated with both the translocated and unrearranged 
  CCND1   loci in cell lines with t(11;14). Interestingly, binding 
of these proteins at the unrearranged   CCND1   locus is depen-
dent on the presence of the translocated allele. These results 
provide further evidence that long-distance control of DNA 
methylation in mammalian cells can be communicated in 
trans, and demonstrate a novel mechanism for chromosome 
structure and nuclear organization to participate in deregu-
lated gene expression in human malignancy. 
    RESULTS   
  B cell lines that have lost the t(11;14) translocation do not 
express cyclin D1 and have altered DNA methylation 
patterns at the unrearranged   CCND1   locus 
  A gene targeting strategy was designed to study regulatory 
regions involved in cyclin D1 deregulation in human B cell 
    Figure 2.         Analysis of D-type cyclin protein levels in parental and 
mutant clones.   (A) IP Western blot analysis of cyclin D1 protein in pa-
rental and mutant NCEB and Granta MCL cell lines. Cyclin D1 protein is 
not detectable in mutant clones. (B) IP Western blot analysis of cyclin D1 
protein in control and mutant U266 MM clones. Parental U266 cells ex-
press cyclin D1 protein, whereas all the mutant clones express no cyclin 
D1 protein. (C) Western blot analysis of cyclin D3 protein in parental and 
cyclin D1        MM and MCL cells. Abundant cyclin D3 protein is observed in 
cyclin D1        cell lines. Parental MCL and MM lines express minimal 
amounts of cyclin D3 protein. The white line indicates that intervening 
lanes have been spliced out. (D) Western blot analysis of cyclin D2 protein 
in parental and cyclin D1        MCL clones. Cyclin D2 protein is present at 
low levels in both parental and cyclin D1        clones. Chicken DT40 cells 
were used as a negative control. Manca (Ma), RD, and DHL-4 cells were 
used as positive controls. M, marker.     1846 TRANSVECTION IN MCL   | Liu et al. 
  DNA methylation in the cyclin D1        genetic variants was 
also assayed by methylation-specifi  c PCR (MSP) (  25  ), which 
complements the Southern blotting and sodium bisulfi  te se-
quencing approaches (  26  ). MSP analysis of the   CCND1   pro-
moter and the 3-kb upstream regions in Granta, NCEB, G4, 
and N1 cells revealed that both regions were heavily CpG 
methylated in the genetic variants (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20072102/DC1). 
  These data are consistent with a model in which the trans-
located chromosome exerts a transallelic hypomethylating 
eff  ect on the nontranslocated chromosome in MCL parental 
cell lines. This eff  ect disappeared in the targeted variants with 
the loss of the translocated chromosome, leading to exten-
sive methylation of the   CCND1   locus. The transallelic hypo-
methylating eff  ect extended from the   CCND1   promoter at 
least to the P519 region 90 kb upstream. 
  To determine if our observations in MCL cells were ap-
plicable to cyclin D1  –  expressing MM cells that contained an 
depicted) and protein (  Fig. 2 C  ) levels was observed, pre-
sumably to compensate for the loss of cyclin D1 that has 
been observed in other experimental cell culture and animal 
systems (  23, 24  ).   
  DNA methylation patterns within the   CCND1   locus in 
the variant cyclin D1        MCL cells were analyzed. The  CCND1   
promoter region and sequences 3 kb upstream were exten-
sively methylated, as shown by Southern blot analysis (  Fig. 3 B  ) 
and bisulfi  te sequencing (  Fig. 3 C  ).   DNA methylation changes 
occurred in sequences 90 kb (P519) upstream of the   CCND1   
gene. Because the translocation breakpoints in the NCEB and 
Granta cell lines are located at the 3     end and proximal to the 
MTC (  Fig. 3 A  ), respectively, most of this region lies on the 
reciprocal translocation partner. At the MTC, CpG sequences 
such as at the Hpa II/Msp site remained hypomethylated in 
both cyclin D1-expressing and nonexpressing clones. Similar 
results were obtained with independently isolated Granta and 
NCEB clones (  Fig. 3, B and C  ). 
    Figure 3.         DNA methylation analysis of the parental and cyclin D1        cell lines.   (A) Schematic representation of the 11q13 locus. Breakpoints, probes used, 
regions studied by bisulfi  te sequencing, and their positions relative to the   CCND1   gene are shown. (B) Analysis of DNA methylation in Granta (G) versus G4, LG1, 
and LG2 cell lines, and NCEB (N) versus N1, N2, and N3 cell lines. Isolated DNA from each line was cut with Hind III + Msp (M) or Hpa II (H) and Southern blotted. 
(C) Bisulfi  te sequencing in G4 and N1 cell lines. Extensive remethylation of the promoter and 3-kb upstream regions compared with parental cell lines Granta and 
NCEB, and remethylation of some sites in the P519 region located 90 kb upstream of the   CCND1   gene are observed. (D) Analysis of DNA methylation in U266 and 
variant cell lines by Southern blotting. The   CCND1   promoter region and upstream region P519 are unmethylated in U266 cells and methylated in nonexpressing 
LU1 and LU2 cells.   CCND1  -expressing MM cell lines KMS12 and KMS21BM (t(11;14)+) are unmethylated in all regions examined, similar to U266 cells.    JEM VOL. 205, August 4, 2008 
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  Analysis of the DNA methylation status at the   CCND1   lo-
cus in the parental MM cell lines and the U266 cyclin D1        de-
rivatives revealed that the   CCND1   promoter and P519 regions 
were hypomethylated in all of the cyclin D1  +   MM cell lines, 
including U266, KMS12, and KMS21BM (  Fig. 3 D  ), similar to 
the results obtained with the parental Granta and NCEB MCL 
cell lines. In contrast, DNA hypermethylation was observed at 
the   CCND1   locus in the cyclin D1        U266 MM cell lines that 
had lost the active   CCND1   locus with inserted IgH regulatory 
insertion of IgH sequences instead of the classical t(11;14), we 
analyzed similar variant clones from parental U266 cells that 
contain IgH regulatory sequences inserted     10 kb centromeric 
of the   CCND1   promoter (  12  ). Similar to the variant Granta and 
NCEB clones, U7, LU1, and LU2 clones were isolated where 
the active chromosome 11 was lost (  Fig. 1 E  ; and Table S1), and 
no cyclin D1 protein was detected (  Fig. 2 B  ). In addition, two 
other control MM cell lines that contain t(11;14) and express 
cyclin D1 (KMS12 and KMS21BM) (  27  ) were analyzed. 
    Figure 4.         Histone acetylation analyses in parental and cyclin D1        MCL lines.   (A) Map of the 11q13 and 14q32 loci, as in   Fig. 1 A  . Primers used and 
their positions relative to the   CCND1   and  C    genes are shown. (B) ChIP assays with antibodies to acetylated histones H3 and H4 demonstrated hyper-
acetylation in the parental cell lines Granta (G) and NCEB (N), and hypoacetylation in the mutant cell lines G4 and N1 at the   CCND1   promoter and up-
stream 3-kb (UP3K) regions. The other regions, including upstream regions   MyeOV , MTC, P519, the   CCND1   gene intron 4, and the IgH regulatory elements 
showed high levels of histone acetylation. (C) ChIP assays of H3 AcK9 showing a similar pattern as that obtained in B. White lines indicate that interven-
ing lanes have been spliced out. (D) Schematic diagram of the   CCND1   gene showing the location of the primers (left and right arrows) used for PCR and 
the polymorphic BsrI/NciI site, located in the last codon of exon 4 (A870G; reference   30  ). BsrI digestion of the PCR products distinguishes two alleles: 
allele A (145 and 22 bp) and allele G (167 bp). (E) ChIP RFLP assay of the   CCND1   promoter region in U266 cells. Acetylated histones are only detected on 
the translocated allele, suggesting no transvection effects as observed with DNA methylation. N, normal allele; T, translocated  allele.   1848 TRANSVECTION IN MCL   | Liu et al. 
tone acetylation patterns in the cyclin D1        genetic variants 
and parental cell lines were studied by chromatin immunopre-
cipitation (ChIP) assays. In contrast to the parental cell lines, 
the cyclin D1 coding and promoter regions and sequences ex-
tending 3 kb upstream were histone H3 and H4 deacetylated 
in the mutant cell lines, consistent with the DNA methylation 
patterns and the lack of transcription of the cyclin D1 gene. 
However, regions far upstream of the cyclin D1 gene, includ-
ing the MTC, P519, and the IgH regulatory regions, remained 
histone H3 and H4 hyperacetylated in the mutant cell lines 
(  Fig. 4 B  ) (  4  ).   Similar results were obtained with specifi  c anti-
bodies to acetyl H3 lysine 9 (AcK9;   Fig. 4 C  ). 
  Because the changes in histone acetylation observed in 
the mutant cells were also consistent with the loss of the his-
tone H3 and H4 acetylated, translocated allele, allele-specifi  c 
histone acetylation assays were performed. Specifi  cally, we 
wished to determine whether both the translocated and non-
translocated   CCND1   alleles in the parental cells contained 
acetylated histones. Allele-specifi  c patterns of histone acetylation 
were studied in the U266 MM cell line, whose cyclin D1 
  alleles can be distinguished by a polymorphism at the cyclin 
D1 intron/exon 4 junction (  Fig. 4 D  ). Allelic ChIP assays 
performed on U266 cells indicated that acetylated histones 
were only present on the translocated allele (  Fig. 4 E  ), sug-
gesting that histone acetylation was not participating in trans-
allelic eff  ects at the   CCND1   locus. 
  Reintroduction of the translocated t(11;14) alters DNA 
methylation in trans 
  Somatic cell fusion experiments have been used to study the 
contribution of individual alleles to both the transcription and 
DNA methylation status of several genetic loci in human ma-
lignancy (  28, 29  ). Thus, cell fusion was used to determine if 
reintroduction of the translocated chromosome into the mu-
tant cell lines where the   CCND1   locus was methylated was 
capable of eff  ecting transhypomethylation of the methylated 
allele. The Granta cell line (  CCND1   hypomethylated) was 
fused with the N1 cell line (  CCND1   methylated) to enable use 
of a DNA polymorphism within the   CCND1   gene (  30  ) to 
distinguish the translocated from the normal   CCND1   loci 
(  Fig. 5, A and B  ).   All of the hybrid (G/N1) clones isolated 
contained both the untranslocated   CCND1   locus from N1 
cells and the translocated   CCND1   locus from Granta cells, and 
expressed cyclin Dl (  Fig. 5, C  –  F  ). No hybrid clones could be 
isolated that contained only the nontranslocated   CCND1   loci 
(see Discussion). RFLP analysis demonstrated that cyclin D1 
gene expression in these G/N1 hybrid clones originated from 
the Granta cell  –  derived translocated   CCND1   locus (  Fig. 5 E  ). 
  DNA methylation in the hybrid G/N1 cells was analyzed 
using Southern blotting (  Fig. 5 G  ) and sodium bisulfi  te se-
quencing (  Fig. 6  ) to determine whether introduction of the 
translocated   CCND1   locus was capable of eff  ecting trans-
hypomethylation of the methylated allele.   A 1:1 mix of the 
two parental DNAs and DNAs from nonhomologous clones 
were used as controls (Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20072102/DC1). Analysis of DNA 
elements. Thus, transallelic eff  ects at the   CCND1   locus are ob-
served with inserted as well as translocated IgH sequences. 
  Monoallelic histone acetylation patterns at the cyclin D1 loci 
  To determine if posttranslational histone modifi  cations such as 
histone acetylation were coordinately involved with DNA 
methylation in transallelic eff  ects at the cyclin D1 locus, his-
    Figure 5.         Characterization and analysis of G/N1 hybrid cells.  
(A) Schematic diagram of the somatic cell fusion strategy used to generate 
G/N1 hybrid cells. (B) Schematic diagrams showing the location of the 
primers (arrows) used for PCR (  Fig. 4 D  ) or RT-PCR and the polymorphic 
BsrI/NciI site (A870G; reference   30  ). BsrI or NciI digestion of the PCR or RT-
PCR products distinguishes two alleles (A and/or G). (C) Allelic   CCND1   gene 
PCR-RFLP analysis. Granta cells had the GG genotype, the mutant cell 
line N1 had the A genotype, and G/N1 hybrid cells had the AG genotype. 
(D) RT-PCR analysis demonstrated cyclin D1 expression in the G/N1 hybrid 
cells. Granta was used as positive control. N1 was used as a negative con-
trol and actin was used as an amplifi  cation control. (E) Allelic   CCND1   RT-
PCR analysis. The hybrid cells contain the translocated and transcriptionally 
active   CCND1   locus, as in Granta cells. N1 and N cells were used as con-
trols. (F) Southern blot analysis of the genomic DNA cleaved with BamH1 
from Granta (G) and G/N1 hybrid cells shows both the normal and trans-
located   CCND1   loci. (G) Southern blot analysis of DNA methylation in the 
G/N1 hybrid, Granta, and N1 cell lines. The   CCND1   promoter region and 
upstream regions P519 and MTC are hypomethylated in G/N1 hybrid cells.     JEM VOL. 205, August 4, 2008 
ARTICLE
1849
of the promoter from the unrearranged, methylated   CCND1   
allele in G/N1 hybrid cells containing both the translocated 
and nonrearranged   CCND1   loci. Extensive hypomethylation 
methylation patterns by bisulfi  te sequencing and MSP (  Fig. 6  ) 
demonstrated that the translocated   CCND1   locus was able to ef-
fect DNA hypomethylation at the promoter and 3 kb upstream 
    Figure 6.         Transallelic effects are specifi  c to t(11;14).   (A) Granta cells demonstrated minimal DNA methylation in the   CCND1   gene promoter region. 
G/N1 hybrid cells showed     20% methylation, whereas the 1:1 mixture of Granta and N1 showed     50% methylation (    100% methylation in N1 cells, as 
shown in   Fig. 3 C  ; and Fig. S2, available at http://www.jem.org/cgi/content/full/jem.20072102/DC1). Low-level DNA methylation was found in the upstream 
3-kb region in both Granta and hybrid (G/N1) cells, whereas N1 cells displayed     100% methylation, as shown in   Fig. 3 C  . (B) Methylation levels in hybrid cells 
increased to     40% with culture (G/N1 late). (C) Hybrid cells treated with 5-azacytidine alone (G/N1 aza) or the combination of 5-azacytidine and tricho-
statin A (G/N1 TSA + aza) showed decreased methylation levels at the   CCND1   gene promoter region compared with untreated cells (B) or cells treated with 
trichostatin A alone (G/N1 TSA). (D) MSP analysis at the   CCND1   3-kb upstream region was performed as in Fig. S1. Methylation was observed in N1, U7, and 
LCL/N1 hybrid cells but not in parental NCEB, U266, or hybrid G/N1 cells, or in the malignant lymphocytes of a patient with a 11q     deletion and no t(11;14).     1850 TRANSVECTION IN MCL   | Liu et al. 
    Figure 7.         CTCF and NPM bind to the   CCND1   loci and selectively to 3     IgH regulatory elements in MCL cells.   (A) CTCF, Oct2, and Sp1 showed 
differential binding in the parental cell line Granta (G) and the mutant cell line G4. OCA-B/Bob-1, NF-    B, and Rel-B showed similar low levels of binding in 
both cell lines. White lines indicate that intervening lanes have been spliced out. (B) CTCF, Oct2, and Sp1 are bound to the   CCND1   promoter and IgH regula-
tory regions in MCL cell lines. EBV-transformed B lymphocytes LCL1 and LCL2 showed binding of CTCF, Oct2, and Sp1 at the   CCND1   promoter  region, 
whereas cyclin D1 mRNA was not expressed in these cells. Oct2 and Sp1 bound to the IgH regulatory elements E     and  3    C    HS4 and HS3, whereas CTCF 
was only found bound to the E     intronic enhancer in LCL1. CTCF, Oct2, and Sp1 all bound to the   CCND1   promoter region. H, HL60 myeloid cells; M, Manca 
Burkitt  ’  s lymphoma cells. (C) CTCF binding was enriched at the   CCND1   promoter and IgH regulatory sequences. (D) NPM binding is similar to that of CTCF in 
Granta MCL cells at the   CCND1   locus and IgH regulatory sequences. (E) Model of CTCF tethering of the 3     C    IgH enhancers (E) to the   CCND1   promoter  (P) 
through interaction at the nucleolar periphery. CTCF functions to juxtapose enhancer and promoter by tethering them to the nucleolus through interaction 
with NPM. CTCF is also postulated to tether the normal and translocated   CCND1   loci, thus facilitating transallelic effects (modifi  ed from reference   20  ).     
of the upstream 3-kb region was observed, but the transhypo-
methylation at the   CCND1   promoter was incomplete in G/N1 
hybrids. DNA methylation was reevaluated in these hybrid cells 
after multiple rounds of DNA replication to determine if the 
transhypomethylating eff  ect at the promoter could be magni-
fi  ed (  Fig. 6 B  ). In fact, DNA replication was associated with a 
small increase in   CCND1   promoter methylation. 
  Treatment of these hybrid cells with a DNA hypometh-
ylating agent (5-azacytidine) and/or a histone deacetylase in-
hibitor (trichostatin A) was performed (  Fig. 6 C  ). Treatment 
with 5-azacytidine alone or in combination with trichostatin 
A led to almost total DNA hypomethylation at the   CCND1   
promoter in the hybrid cells, whereas treatment with tricho-
statin A alone did not change DNA methylation patterns. 
  Because hybrid clones containing only the nontranslo-
cated   CCND1   locus could not be isolated (see Discussion), 
control fusions were performed using N1 and lymphocyte 
cell line (LCL) cells to investigate the eff  ects of introduc-
tion of a nontranslocated, hypomethylated   CCND1   locus 
(  4  ) on the densely methylated   CCND1   locus in N1 cells. 
MSP analysis of the   CCND1   3-kb upstream region demon-
strated that in contrast to G/N1 cells, LCL/N1 hybrid cells JEM VOL. 205, August 4, 2008 
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  CTCF has been shown to interact with the nucleolar pro-
tein NPM to tether an insulator sequence to subnuclear sites 
at the nucleolar periphery (  21  ). ChIP assays demonstrated 
binding of NPM at the   CCND1   promoter and IgH regulatory 
regions in MCL cells, similar to results obtained with CTCF 
(  Fig. 7 D  ). These results suggested a potential role for CTCF 
in juxtaposing 3     C     IgH regulatory elements (HS3 and HS4) 
and the   CCND1   promoter by tethering them to the nucleolar 
periphery with NPM. CTCF and NPM could also play a role 
in mediating pairing of the translocated and normal   CCND1   
loci, facilitating transallelic eff  ects (  Fig. 7 E  ). 
  If CTCF and NPM were involved in tethering the   CCND1   
loci together, evidence of binding of these proteins to both 
  CCND1   alleles would be expected. Allelic ChIP assays were 
performed with antibodies to CTCF, NPM, and RNA poly-
merase II (Pol II). MCF7 cells, a cyclin D1  –  expressing breast 
cancer line without the t(11;14) translocation, demonstrated 
biallelic transcription of cyclin D1 (  30  ) as well as biallelic 
binding of Pol II, NPM, and CTCF (  Fig. 8 B  ).   An EBV 
LCL (LCL1) that does not express cyclin D1 demonstrated no 
binding of Pol II or CTCF at either allele, whereas the  CCND1   
loci in this cell line are CpG hypomethylated and histone 
H3 and H4 are hyperacetylated (  4  ). U266 MM cells only 
transcribed the   CCND1   allele containing the IgH insertion, 
did not demonstrate hypomethylation in trans at the   CCND1   
locus (  Fig. 6 D  ). 
  To further demonstrate that transallelic eff  ects in MCL 
were specifi  c to t(11;14), malignant lymphoid cells that had 
deleted one   CCND1   allele without the presence of t(11;14) 
were studied. A variant MCL patient (  31  ) with marked peri-
pheral blood lymphocytosis was identifi  ed (expressing cyclin 
D3 and no cyclin D1 mRNA; not depicted). FISH analysis 
demonstrated that this patient  ’  s malignant B cells contained a 
deletion of one allele of chromosome 11q, including the cyclin 
D1 locus (Fig. S3, available at http://www.jem.org/cgi/content/
full/jcb.20072102/DC1), and no t(11;14). MSP analysis of this 
11q     patient  ’  s DNA demonstrated a hypomethylated   CCND1   
allele (  Fig. 6 D  ). Thus, transallelic eff  ects were specifi  c to the 
presence of the translocated   CCND1   locus. 
  CTCF, NPM, and the nucleolus are associated with cyclin D1 
activation and transvection 
  ChIP assays were used to screen parental versus variant cyclin 
D1        G4 cells for DNA binding proteins that would demon-
strate selective binding to the translocated, transcriptionally 
active allele (  Fig. 7  ).   Proteins were assayed that have been re-
ported to bind to the   CCND1   promoter in vitro or whose 
potential consensus binding sites are located in the   CCND1   
promoter and IgH regulatory regions (  32  –  35  ). Our results 
demonstrated that CTCF, Oct2, and Sp1 exhibited selective 
in vivo binding at the   CCND1   promoter region in G versus 
G4 cells, whereas OCA-B (Bob-1), NF-    B, or a subunit of 
NF-    B (Rel-B) did not. Additional ChIP assays were per-
formed to further study in vivo DNA  –  protein interactions 
of CTCF, Oct2, and Sp1 at the   CCND1   promoter, and IgH 
regulatory regions in cyclin D1  –  expressing and control cell 
lines. Oct2, Sp1, and CTCF binding to the   CCND1   promoter 
region correlated with cyclin D1 gene expression in MCL 
cells (  Fig. 7 B  ). Primers from the IgH E     enhancer 3     C     
LCR regions showed CTCF, Oct2, and Sp1 binding to the 
E     enhancer in both MCL and LCL cells. CTCF but not 
Oct2 or Sp1 binding to 3     C     LCR HS3 and HS4 correlated 
with cyclin D1 expression (  Fig. 7 B  ). 
  The binding of CTCF at the   CCND1   locus and IgH regula-
tory regions was further examined using ChIP assays (  Fig. 7 C  ). 
Although binding at IgH 3     C     LCR HS3 and HS4 only oc-
curred in cell lines that expressed   CCND1  , primers for 3     C     
HS12 demonstrated binding of CTCF in all cell lines exam-
ined (  Fig. 7 C  ). Collectively, these results suggested that 3     
C     HS3 and HS4 binding by CTCF could be important in 
deregulated cyclin D1 expression in MCL. 
  Western blot analyses were performed to assay the level 
of these proteins in the cell lines used (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20072102/DC1). 
cyclin D1 protein was detected in the MCL cell lines Granta 
and NCEB, and the breast cancer cell line MCF7, consistent 
with RT-PCR assays (  4  ). The transcription factors CTCF, 
Oct2, and Sp1 were detected in all cell lines examined. Thus, 
the specifi  c binding of CTCF observed was not secondary to 
variations in the levels of this protein in MCL cells. 
    Figure 8.         CTCF and NPM bind at both the translocated and normal 
  CCND1   alleles.   (A) Allelic   CCND1   RT-PCR assay. The 145-bp fragment 
corresponds to the translocated and transcribed   CCND1   locus in U266 
cells, whereas the 164-bp fragment corresponds to the translocated locus 
in Granta cells. Both   CCND1   loci of MCF7 cells are transcribed. N, normal; 
T, translocated   CCND1   alleles. (B) Allelic ChIP assays. CTCF and NPM bind-
ing is seen on both   CCND1   loci and Pol II binding only on the translocated 
and transcribed locus (145-bp band shown, as in   Fig. 5 B  ) in U266. MCF7 
cells bind CTCF and Pol II at both   CCND1   loci, and an LCL B cell line showed 
no binding of CTCF and Pol II. (C) ReChIP assay of CTCF and NPM binding 
to the   CCND1   locus in MCL cells. ChIP assays with CTCF and NPM antibodies 
sequentially in both combinations were performed in HBL-2 MCL cells. 
PCR analysis with primers from the   CCND1   locus (10 kb upstream;   Fig. 4  ) 
demonstrated that CTCF and NPM were bound together at the cyclin D1 
locus in HBL-2 MCL cells. Mouse IgG and no antibody controls showed no 
binding. White lines indicate that intervening lanes have been spliced out.     1852 TRANSVECTION IN MCL   | Liu et al. 
    Figure 9.         CTCF and NPM participate in tethering of the translocated and nontranslocated   CCND1   loci at the nucleolus.   (A) immunoFISH as-
says demonstrate colocalization of   CCND1   probe (green) and NPM protein (red) at the nucleolar periphery in Granta MCL cells (merge; yellow). DAPI-
stained nuclei are shown in blue. (B) immunoFISH assays (as in A). Paired   CCND1   loci as demonstrated by two juxtaposed FISH spots (arrows) colocalize 
with nucleoli in cells from Granta cells (top) and an MCL patient (bottom). Insets show different fi  elds of view. (C) immunoFISH assays of Granta cells with 
  CCND1   (red) /IgH (green) probes and NPM antibodies (Cy5; gray), demonstrating colocalization of both translocated chromosome partners (yellow) at the 
nucleolar periphery. (D) G4 cells lacking the translocated   CCND1   locus exhibit colocalization of the   CCND1   FISH signal with the nucleoli. (E) immunoFISH 
assay of MCF7 cells (FISH probes as in D) demonstrates no colocalization of the   CCND1   locus with the nucleoli. (F) immunoFISH assay of LCL1 B lympho-
cytes (FISH probes as in D) demonstrates no colocalization of the   CCND1   locus with the NPM-stained nucleoli. (G) Z stack images (deconvolution microscopy; JEM VOL. 205, August 4, 2008 
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down levels of NPM. Cell growth was specifi  cally inhibited by 
NPM shRNA in cell lines containing a t(11;14) but not in 
B lymphocytes without this translocation and MCF7 cells (  Fig. 
10 A  ).   Western blotting demonstrated signifi  cant knockdown 
of NPM protein levels but no change in cyclin D1 protein lev-
els in either MCF7 or Granta cells (  Fig. 10 B  ). Western analysis 
showed a marked decrease in NPM levels in cells containing 
the NPM shRNA (  Fig. 10 C  ). The NCEB MCL cell line dem-
onstrated marked morphological changes that were consistent 
with apoptosis and were confi  rmed by Tdt-mediated dUTP-
biotin nick-end labeling (TUNEL) assays. Lower levels of apop-
tosis were observed in Granta cells (  Fig. 10 D  ), and minimal 
apoptosis was seen in G4 and N1 cells (Fig. S6, available at 
http://www.jem.org/cgi/content/full/jem.20072102/DC1). 
MCF7 and K562 erythroleukemia cells treated with the NPM 
but not control shRNA vectors showed loss of nucleolar NPM 
staining, and CTCF, cyclin D1, and residual NPM staining in 
the cytoplasm (  Fig. 10 C  ). These results are consistent with the 
role of NPM as a shuttle protein (  38  ) and suggest that CTCF and 
cyclin D1 are among the proteins regulated by NPM. immuno-
FISH assays revealed no signifi  cant change in nucleolar co-
localization of the   CCND1   loci in NPM knockdown cells 
(  Fig. 10 E  ), suggesting that additional layers of complexity are 
involved in the tethering of the   CCND1   loci in MCL cells. 
NPM knockdown cells also did not demonstrate any change in 
cyclin D1 protein levels (  Fig. 10 B  ), suggesting that NPM bind-
ing at the   CCND1   locus was not directly involved in regulating 
expression of the cyclin D1 gene but could be serving a struc-
tural role in tethering the   CCND1   loci to the nucleolus. 
    DISCUSSION   
  Previously, the DNA methylation patterns of the 11q13 re-
gion surrounding the   CCND1   gene in MCL and MM cells 
were examined (  4  ). The activation of the cyclin D1 gene by IgH 
regulatory elements was found to correlate with the absence 
of DNA methylation at the   CCND1   promoter. Interestingly, 
this domain of hypomethylated DNA appears to be present 
not only on the translocated but also on the untranslocated 
allele. Normal B cells and EBV lymphocytes also displayed 
extensive DNA hypomethylation and hyperacetylation of his-
tones at the   CCND1   loci, although the   CCND1   gene is not 
expressed (  4  ). Hypomethylation up to 90 kb upstream of the 
  CCND1   promoter was eliminated with loss of the translocated 
chromosome initiated through a gene targeting event. 
  Somatic cell hybrid fusions indicated that reintroduction 
of the translocated chromosome but not a nontranslocated 
chromosome was capable of transhypomethylating a densely 
methylated   CCND1   locus. The Granta cells used in the fu-
sion experiments that reintroduced the t(11;14) chromosome 
FISH probes as in D) show nucleolar colocalization of translocated chromosomes in Granta cells. Nucleoli are blue and DAPI-stained nuclei are gray. 
The nucleoli are seen as DAPI-poor staining regions (FISH-DNA) that stain with anti-NPM antibodies (FISH  –  DNA NPM). (H) Quantitative analysis of the 
percentage of nucleolar colocalization and   CCND1   locus pairing in Granta cells, cells from three MCL patients (Pts), and MCF7 cells using   CCND1   (D1;  see 
A – C),   CCND1  /IgH fusion (Trans; probe used in D  –  G), FISH probes, and NPM antibodies. At least 100 nuclei were scored per sample. G1 cell cycle phase 
nuclei isolated by fl  ow cytometry were used. Error bars show SEM. Bars, 5   μ  m.     
 
as shown by RT-PCR analysis and ChIP analysis using Pol 
II antibodies (  Fig. 8, A and B  ). However, CTCF and NPM 
ChIP DNA from U266 but not LCL cells contained sequences 
from both the transcribed and nontranscribed   CCND1   alleles 
(  Fig. 8 B  ). Thus, both the transcribed and nontranscribed 
  CCND1   loci bind CTCF and NPM, consistent with our hypo-
thesis that CTCF and NPM are involved in tethering these 
loci together. 
  To provide further evidence that CTCF and NPM were 
directly cobinding at the   CCND1   locus, sequential ChIP (  36  ) 
assays were performed on the EBV-negative MCL cell line 
HBL-2 (  37  ) using sequential IP assays with anti-CTCF and 
NPM antibodies. These results demonstrated that CTCF and 
NPM were binding together at the   CCND1   locus in MCL 
cells (  Fig. 8 C  ). 
  FISH analysis combined with NPM immunofl  uorescent 
FISH (immunoFISH) staining was used to visualize the position 
of the   CCND1   loci in relationship to the nucleolus. Fixation 
protocols using methanol/acetic acid or paraformaldehyde 
alone, or in combination, yielded similar results. The  CCND1   
locus colocalized at the nucleolar periphery in   CCND1  -trans-
located cell lines (  Fig. 9, A and G  ) and in neoplastic cyclin 
D1  –  expressing lymphocytes from MCL patients (  Fig. 9 B  ; 
and Fig. S5, available at http://www.jem.org/cgi/content/
full/jem.20072102/DC1).   Pairing of the   CCND1   loci at the 
nucleolus was also observed, as indicated by two juxtaposed 
FISH signals ( Fig. 9, B and C; and G and H ). The paired  CCND1   
loci observed were unlikely to be caused by replicated but 
unseparated sister chromatids, because the same frequency of 
pairing was observed in fl  ow-sorted Granta nuclei in the G1 
cell cycle phase (  Fig. 9 H  ). Paired   CCND1   loci were not 
observed in cyclin D1  –  expressing MCF7 cells and LCL cells 
where the   CCND1   locus was hypomethylated and histone 
H3 and H4 were acetylated (  4  ). 
  In MCL cells that lost the translocated   CCND1   locus (G4), 
the nontranslocated chromosome 11 remained associated with 
the nucleolus, providing further evidence that pairing of the 
cyclin D1 loci at the nucleolus was occurring in the parental 
MCL cell lines (  Fig. 9, D and H  ). These observations dem-
onstrated the nucleolar environment is capable of both acti-
vation and repression functions at the   CCND1   loci in MCL 
cells (see Discussion). In cyclin D1  –  expressing MCF7 cells, B 
lymphocytes (LCLs), and the variant MCL patient (Fig. S4) 
that do not contain the t(11;14) translocation, colocalization of 
the   CCND1   loci and the nucleolus was not observed (  Fig. 9, E 
and F  ; and not depicted). 
  To further investigate the role of the nucleolus and NPM 
in deregulated cyclin D1 expression in t(11;14) B cell malig-
nancies, we used NPM short hairpin RNA (shRNA) to knock 1854 TRANSVECTION IN MCL   | Liu et al. 
sessed a diff  erent, distinguishable polymorphism in the cyclin 
D1 gene (  Fig. 5  ). All of the hybrid clones isolated contained 
the translocated chromosome. We were unable to isolate 
into N1 cells also contained a nontranslocated   CCND1   locus 
that possessed the identical cyclin D1 polymorphism as the 
translocated   CCND1   locus. The recipient N1 cell line pos-
    Figure 10.         NPM knockdown in MCL and control cells.   (A) Growth of cells containing t(11;14) translocations is inhibited with NPM shRNA. Cells 
were infected with retroviruses containing either an NPM (red) or a control (blue) shRNA. Cell growth was specifi  cally inhibited in cells with t(11;14) 
translocations. (B) Western blot analysis of protein levels of cyclins D1, D3, NPM, and     -tubulin genes after infection with NPM shRNA virus. NPM levels 
are reduced, whereas levels of cyclins D1 (Granta and MCF7) and D3 (K562) are unchanged. (C) Immunofl  uorescent staining of NCEB, MCF7, and K562 
cells after transfection with NPM shRNA vector. NPM shRNA  –  infected NCEB cells show dramatic morphological changes. MCF7 cells demonstrated cyclin 
D1 and CTCF cytoplasmic protein staining. K562 erythroleukemia cells also demonstrate cytoplasmic NPM and CTCF staining. Granta NPM shRNA  –  treated 
cells do not show cytoplasmic localization of NPM or cyclin D1. (D) TUNEL assays of NPM and control shRNA MCL cells. Fig. S6 (available at http://www
.jem.org/cgi/content/full/jem.20072102/DC1) shows control shRNA vector  –  infected cells. (E) immunoFISH assay of NPM knockdown Granta cells demon-
strates no signifi  cant change in the percentage of cells showing nucleolar localization. Error bars in A, D, and E show SEM. Bars, 5   μ  m.     JEM VOL. 205, August 4, 2008 
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clones that contained only the nontranslocated   CCND1   lo-
cus from Granta cells. Thus, the translocated and nontrans-
located   CCND1   loci could not be segregated. This result 
provides further, albeit indirect, evidence that the translo-
cated and nontranslocated cyclin D1 loci are tethered 
together (at the nucleolus), as suggested by our immunoFISH 
data (  Fig. 9  ). Alternatively, defects in DNA methylation have 
been associated with chromosomal instability, both in embryo-
genesis (  39  ) and in colorectal cancer cell lines (  40  ). Therefore, 
another possibility is that the hypomethylated nontranslo-
cated   CCND1   locus was unstable and was lost during the cell 
fusion process. 
  Control fusion experiments indicated that fusion of N1 
cells with a B lymphocyte line without a translocated chro-
mosome was unable to hypomethylate the densely methyl-
ated cyclin D1 locus of N1 cells in trans. Similar results using 
other systems demonstrated no trans epigenetic eff  ects with 
nontranslocated chromosomes (  28, 29  ). 
  Because the   CCND1   locus is extensively hypomethyl-
ated in normal B cells, at least three DNA methylation states 
of the   CCND1   loci are implied: (a) normal B cells in where 
both   CCND1   loci are unmethylated and independent; (b) B 
cells containing   CCND1   translocations/insertions, where the 
translocated locus exerts a transhypomethylating eff  ect on the 
untranslocated locus; and (c) B cells that have lost the trans-
located chromosome and where the   CCND1   locus is CpG 
methylated. The second and third DNA methylation states 
are dependent on localization at the nucleolus, whereas the 
second DNA methylation state appears to be associated with 
pairing of the   CCND1   loci. Thus, the association of genetic 
loci with the nucleolus can result in either active (state 2) or 
inactive (state 3) chromatin, consistent with the results ob-
tained in other systems (  21, 41  ). The mechanisms involved in 
gene expression or repression by association with the nucleo-
lus remain obscure, but could be related to the ability of the 
translocated allele to recruit activator molecules that protect 
the tethered cyclin D1 loci from the general repressive eff  ects 
of the nucleolus. There may also be subtle diff  erences in nu-
cleolar localization that may be important in epigenetic acti-
vation versus repression. 
  The change in DNA methylation patterns observed in 
the normal   CCND1   locus after loss of the translocated chro-
mosome are consistent with transallele sensing eff  ects (  42  ), 
which are well studied in   Drosophila   (transvection; references 
  42  –  44  ) and plants (paramutation) (  13  –  15  ). Trans eff  ects in 
both endogenous and transgenic mouse loci have been re-
ported (  45  –  49  ). Such eff  ects often involve DNA methylation 
and occur over long distances (  45, 46, 48  ). Transactivation of 
the endogenous   Igf2   gene by trangenes has been reported (  49  ), 
but given the results reported in this paper, transallelic eff  ects 
should be considered. 
  Recent observations in transgenic mice have described 
paramutation-like eff  ects at the   Igf2   (  45  ),   U2af1rs-1   (  46  ),   c-kit   
(  47  ), and   Rosa26   (  48  ) loci. Paramutation/transvection in hu-
man genetic disease associated with the susceptibility to type I 
diabetes has been suggested at the insulin minisatellite vari-
able number tandem repeat element (  50  ). However, our ob-
served transallelic eff  ects are similar to transvection but diff  er 
from paramutation because the DNA transhypomethylation 
eff  ects are not heritable in the absence of the inducer (trans-
located) allele (  14  ). 
  Physical evidence of transcommunication has recently been 
observed between loci on nonhomologous chromosomes 
regulated by the T cell enhancers/LCRs (  51  ), and the   Igf2/
H19   and   Wsb1/Nf1   loci (  52  ). CTCF has been demonstrated 
to be involved in long-distance cis and trans eff  ects at the 
  Igf2/H19   locus (  52, 53  ). Thus, transcommunication may be 
an important means of regulation in mammalian cells. 
  At least two nonexclusive mechanisms are implicated in 
the homology-based transfer of DNA methylation patterns 
(  14  ). One mechanism involves direct communication between 
homologous chromosomes, as has been demonstrated in im-
printed loci (  54  ) or in mouse embryonic stem cells at the 
onset of X inactivation (  55  ). Recent work has shown that 
CTCF is required for this transient X chromosome pairing 
(  56  ). The nucleolus has also been implicated in silencing of 
the inactive X chromosome using immunoFISH assays simi-
lar to those performed in this study (  57  ). Our FISH and allelic 
ChIP data provide evidence for direct communication of the 
  CCND1   alleles in MCL cells that we suggest is mediated via 
CTCF, NPM, and the nucleolus. 
  Alternatively, small RNA molecules have been shown to 
direct chromatin modifi  cation in trans in plants and   Drosophila   
(  13, 14, 58  –  61  ). This epigenetic silencing mechanism involves 
CpG and non-CpG DNA methylation in plants. Tandem and 
inverted repeats have been shown to be involved in this type 
of RNA-mediated repression (  58  –  61  ). More recently, a para-
mutation-like eff  ect mediated by small RNAs has been de-
scribed at the mouse   c-kit   locus (  47  ). 
  Our allelic ChIP and immunoFISH data suggest that CTCF 
and NPM participate in transallelic interactions by tethering 
the cyclin D1 loci from both translocated and nontranslocated 
cyclin D1 loci together at the nucleolar periphery, as depicted 
in   Fig. 7 E  . Our data demonstrate that the 3     C     IgH LCR 
region is suffi   cient to mediate this eff  ect and that CTCF bind-
ing to 3     C     LCR HS3 and HS4 correlates with cyclin D1 
activation in MCL cells. 
  Our fi  nding in cyclin D1  –  deregulated B cell malignancies 
represents the fi  rst report of the association of transvection 
with human cancer. The critical role of NPM in t(11;14) B 
cell malignancies is demonstrated by growth arrest and apop-
tosis selectively in t(11;14) cell lines with NPM shRNA. Our 
data also suggest a novel approach to therapy of t(11;14) ma-
lignancies using agents targeting NPM. 
  MATERIALS AND METHODS 
  Cell culture, electroporation, and retroviral infection.     Cell lines 
were obtained and maintained as previously described (  4  ). The HBL-2 MCL 
cell line (  37  ) was provided by S. Dave (National Cancer Institute, Bethesda, 
MD).   Fig. 1   shows details of gene targeting constructs. Electroporations 
were performed, as previously described (  22  ), using 10  –  20   μ  g of linearized 
targeting vector. Retroviral infections were performed as previously de-
scribed (  62  ). 1856 TRANSVECTION IN MCL   | Liu et al. 
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